You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 45 Body composition as a predictive and prognostic biomarker in advanced urothelial carcinoma (UC) patients treated with immune checkpoint inhibitors (ICI)

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Biomarkers, immune monitoring, and novel technologies
45 Body composition as a predictive and prognostic biomarker in advanced urothelial carcinoma (UC) patients treated with immune checkpoint inhibitors (ICI)

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 20208508
Dec 202056020
Jan 20212409
Feb 20211802
Mar 20216806
Apr 20214206
May 20211103
Jun 2021008
Jul 2021007
Aug 2021005
Sep 2021002
Oct 202118019
Nov 202132021
Dec 20213604
Jan 20222203
Feb 20221803
Mar 20221200
Apr 20224202
May 20221409
Jun 20223003
Jul 20222203
Aug 20221601
Sep 2022602
Oct 20222401
Nov 20221801
Dec 20223402
Jan 20232001
Feb 20234001
Mar 20231004
Apr 20231608
May 20231402
Jun 20232200
Jul 20231804
Aug 20231800
Sep 20231600
Oct 20232203
Nov 20236800
Dec 20233000
Jan 20241801
Feb 20243400
Mar 20242603
Apr 20242402
May 20242602
Jun 20244306
Jul 20244002
Aug 20245702
Sep 20242802
Oct 20242001
Nov 20242603
Dec 20241601
Jan 20251404
Feb 2025601
Mar 2025003
Apr 2025003
May 2025004
Jun 2025006
Total13200219